Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Musella

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
European Journal of Medicinal Chemistry|May 22, 2022
New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer modelsVeronica Di Sarno, Pia Giovannelli, Alicia Medina-Peris, et al.
Journal of Medicinal Chemistry|June 26, 2018
Identification of a Potent Tryptophan-Based TRPM8 Antagonist With in Vivo Analgesic ActivityAlessia Bertamino, Nunzio Iraci, Carmine Ostacolo, et al.
Chemmedchem|May 6, 2025
Novel Para-Phenylenediamine-Based Derivatives as Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) Inhibitors: An In Vitro Preliminary CharacterizationGerardina Smaldone, Maria Rosaria Miranda, Francesca Di Matteo, et al.
Journal of Medicinal Chemistry|August 16, 2022
Beyond Retigabine: Design, Synthesis, and Pharmacological Characterization of a Potent and Chemically Stable Neuronal Kv7 Channel Activator with Anticonvulsant ActivitySimona Musella, Lidia Carotenuto, Nunzio Iraci, et al.
European Journal of Medicinal Chemistry|September 27, 2021
Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterizationVeronica Di Sarno, Gianluigi Lauro, Simona Musella, et al.
Journal of Medicinal Chemistry|December 10, 2019
Synthesis and Pharmacological Characterization of Conformationally Restricted Retigabine Analogues as Novel Neuronal Kv7 Channel ActivatorsCarmine Ostacolo, Francesco Miceli, Veronica Di Sarno, et al.
ACS Chemical Biology|May 1, 2013
Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formationFrancesco Ortuso, Francesco Paduano, Alfonso Carotenuto, et al.
European Journal of Medicinal Chemistry|January 17, 2024
Peptidomimetics as potent dual SARS-CoV-2 cathepsin-L and main protease inhibitors: In silico design, synthesis and pharmacological characterizationTania Ciaglia, Vincenzo Vestuto, Veronica Di Sarno, et al.
Journal of Medicinal Chemistry|July 24, 2025
Untargeted Diversity-Oriented Synthesis for the Discovery of New Antitumor Agents: An Integrated Approach of Inverse Virtual Screening, Bioinformatics, and Omics for Target DeconvolutionTania Ciaglia, Valeria Napolitano, Maria Rosaria Miranda, et al.
Journal of Medicinal Chemistry|June 19, 2023
Design, Synthesis, and Pharmacological Characterization of a Potent Soluble Epoxide Hydrolase Inhibitor for the Treatment of Acute PancreatitisSimona Musella, Danilo D'Avino, Lukas Klaus Peltner, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
European Journal of Medicinal Chemistry|May 22, 2022
New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer modelsVeronica Di Sarno, Pia Giovannelli, Alicia Medina-Peris, et al.
Journal of Medicinal Chemistry|June 26, 2018
Identification of a Potent Tryptophan-Based TRPM8 Antagonist With in Vivo Analgesic ActivityAlessia Bertamino, Nunzio Iraci, Carmine Ostacolo, et al.
Chemmedchem|May 6, 2025
Novel Para-Phenylenediamine-Based Derivatives as Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) Inhibitors: An In Vitro Preliminary CharacterizationGerardina Smaldone, Maria Rosaria Miranda, Francesca Di Matteo, et al.
Journal of Medicinal Chemistry|August 16, 2022
Beyond Retigabine: Design, Synthesis, and Pharmacological Characterization of a Potent and Chemically Stable Neuronal Kv7 Channel Activator with Anticonvulsant ActivitySimona Musella, Lidia Carotenuto, Nunzio Iraci, et al.
European Journal of Medicinal Chemistry|September 27, 2021
Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterizationVeronica Di Sarno, Gianluigi Lauro, Simona Musella, et al.
Journal of Medicinal Chemistry|December 10, 2019
Synthesis and Pharmacological Characterization of Conformationally Restricted Retigabine Analogues as Novel Neuronal Kv7 Channel ActivatorsCarmine Ostacolo, Francesco Miceli, Veronica Di Sarno, et al.
ACS Chemical Biology|May 1, 2013
Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formationFrancesco Ortuso, Francesco Paduano, Alfonso Carotenuto, et al.
European Journal of Medicinal Chemistry|January 17, 2024
Peptidomimetics as potent dual SARS-CoV-2 cathepsin-L and main protease inhibitors: In silico design, synthesis and pharmacological characterizationTania Ciaglia, Vincenzo Vestuto, Veronica Di Sarno, et al.
Journal of Medicinal Chemistry|July 24, 2025
Untargeted Diversity-Oriented Synthesis for the Discovery of New Antitumor Agents: An Integrated Approach of Inverse Virtual Screening, Bioinformatics, and Omics for Target DeconvolutionTania Ciaglia, Valeria Napolitano, Maria Rosaria Miranda, et al.
Journal of Medicinal Chemistry|June 19, 2023
Design, Synthesis, and Pharmacological Characterization of a Potent Soluble Epoxide Hydrolase Inhibitor for the Treatment of Acute PancreatitisSimona Musella, Danilo D'Avino, Lukas Klaus Peltner, et al.
Pageof 6